459 related articles for article (PubMed ID: 17828743)
1. Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions.
Yang T; Roder KE; Abbruscato TJ
J Pharm Sci; 2007 Dec; 96(12):3196-213. PubMed ID: 17828743
[TBL] [Abstract][Full Text] [Related]
2. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
3. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y
Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526
[TBL] [Abstract][Full Text] [Related]
4. Regulation of bovine brain microvascular endothelial tight junction assembly and barrier function by laminar shear stress.
Colgan OC; Ferguson G; Collins NT; Murphy RP; Meade G; Cahill PA; Cummins PM
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3190-7. PubMed ID: 17308001
[TBL] [Abstract][Full Text] [Related]
5. Role of PKCbetaII and PKCdelta in blood-brain barrier permeability during aglycemic hypoxia.
Kim YA; Park SL; Kim MY; Lee SH; Baik EJ; Moon CH; Jung YS
Neurosci Lett; 2010 Jan; 468(3):254-8. PubMed ID: 19900507
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells.
Brown RC; Davis TP
Biochem Biophys Res Commun; 2005 Feb; 327(4):1114-23. PubMed ID: 15652512
[TBL] [Abstract][Full Text] [Related]
7. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
Cohen-Kashi Malina K; Cooper I; Teichberg VI
Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061
[TBL] [Abstract][Full Text] [Related]
8. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
9. Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function.
Colgan OC; Collins NT; Ferguson G; Murphy RP; Birney YA; Cahill PA; Cummins PM
Brain Res; 2008 Feb; 1193():84-92. PubMed ID: 18177846
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation.
Torii H; Kubota H; Ishihara H; Suzuki M
Pharmacol Res; 2007 Feb; 55(2):104-10. PubMed ID: 17157525
[TBL] [Abstract][Full Text] [Related]
11. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells.
Ohtsuki S; Sato S; Yamaguchi H; Kamoi M; Asashima T; Terasaki T
J Cell Physiol; 2007 Jan; 210(1):81-6. PubMed ID: 16998798
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MicroRNA-155 Supports Endothelial Tight Junction Integrity Following Oxygen-Glucose Deprivation.
Pena-Philippides JC; Gardiner AS; Caballero-Garrido E; Pan R; Zhu Y; Roitbak T
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945912
[TBL] [Abstract][Full Text] [Related]
13. Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells.
Shimizu F; Sano Y; Maeda T; Abe MA; Nakayama H; Takahashi R; Ueda M; Ohtsuki S; Terasaki T; Obinata M; Kanda T
J Cell Physiol; 2008 Nov; 217(2):388-99. PubMed ID: 18543246
[TBL] [Abstract][Full Text] [Related]
14. Plant-derived triterpene celastrol ameliorates oxygen glucose deprivation-induced disruption of endothelial barrier assembly via inducing tight junction proteins.
Luo D; Zhao J; Rong J
Phytomedicine; 2016 Dec; 23(13):1621-1628. PubMed ID: 27823626
[TBL] [Abstract][Full Text] [Related]
15. Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells.
Page S; Munsell A; Al-Ahmad AJ
Fluids Barriers CNS; 2016 Oct; 13(1):16. PubMed ID: 27724968
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: influence of astrocyte contact.
Abbruscato TJ; Davis TP
Brain Res; 1999 Sep; 842(2):277-86. PubMed ID: 10526124
[TBL] [Abstract][Full Text] [Related]
17. Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: tight junction proteins and transport properties.
Shi LZ; Li GJ; Wang S; Zheng W
Toxicol In Vitro; 2008 Feb; 22(1):190-9. PubMed ID: 17825520
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
19. Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro.
Nitz T; Eisenblätter T; Psathaki K; Galla HJ
Brain Res; 2003 Aug; 981(1-2):30-40. PubMed ID: 12885423
[TBL] [Abstract][Full Text] [Related]
20. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
